Repository logo
 
Publication

GidB mutation as a phylogenetic marker for Q1 cluster Mycobacterium tuberculosis isolates and intermediate-level streptomycin resistance determinant in Lisbon, Portugal

dc.contributor.authorPerdigão, joão
dc.contributor.authorMacedo, Rita
dc.contributor.authorMachado, Diana
dc.contributor.authorSilva, Carla
dc.contributor.authorJordão, Luísa
dc.contributor.authorCouto, Isabel
dc.contributor.authorViveiros, Miguel
dc.contributor.authorPortugal, Isabel
dc.date.accessioned2013-10-22T12:19:14Z
dc.date.available2013-10-22T12:19:14Z
dc.date.issued2013-09-14
dc.description.abstractDevelopment of streptomycin-resistance in Mycobacterium tuberculosis is usually associated with mutations in rpsL and rrs genes, although up to 50% of clinical streptomycin-resistant isolates may present no mutation in either of these genes. In the present report we investigate the role of gidB gene mutations in streptomycin resistance. We have analyzed 52 streptomycin-resistant and 30 streptomycin-susceptible Mycobacterium tuberculosis clinical isolates by sequencing and endonuclease analysis of the gidB and rpsL genes. All clinical isolates were genotyped by 12-loci MIRU-VNTR. The gidB gene of 18 streptomycin-resistant isolates was sequenced and four missense mutations were found: F12L (1/18), L16R (18/18), A80P (4/18) and S100F (18/18). The remaining isolates were screened by endonuclease analysis for mutations A80P in gidB and K43R in rpsL gene. Overall, mutation A80P in gidB gene was found in 8 streptomycin-resistant isolates and 11 streptomycin-susceptible multidrug resistant isolates. Also noteworthy, is the fact that gidB mutations were only present in isolates without rpsL and rrs mutations, all from genetic cluster Q1. Streptomycin quantitative drug susceptibility testing showed that isolates carrying the gidB A80P mutation were streptomycin intermediate-level resistant and that standard drug susceptibility testing yielded inconsistent results probably due to borderline resistance. We conclude that gidB mutations may explain the high number of streptomycin-resistant strains with no mutation in rpsL or rrs. These mutations might occasionally confer low-level streptomycin resistance that will go undetected in standard susceptibility testing.por
dc.identifier.citationClin Microbiol Infect. 2013 Sep 14. doi: 10.1111/1469-0691.12392.por
dc.identifier.issn1469-0691
dc.identifier.issndoi: 10.1111/1469-0691.12392
dc.identifier.urihttp://hdl.handle.net/10400.18/1769
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherWiley-Blackwell / European Society of Clinical Microbiology and Infectious Diseasespor
dc.relation.publisherversionhttp://onlinelibrary.wiley.com/doi/10.1111/1469-0691.12392/abstract;jsessionid=E03AAAA6F5C386347918E7E00C2C5F7F.f02t04por
dc.subjectM/XDR-TBpor
dc.subjectResistance Levelpor
dc.subjectrrspor
dc.subjectrpsLpor
dc.subjectInfecções respiratóriaspor
dc.titleGidB mutation as a phylogenetic marker for Q1 cluster Mycobacterium tuberculosis isolates and intermediate-level streptomycin resistance determinant in Lisbon, Portugalpor
dc.typejournal article
dspace.entity.typePublication
oaire.citation.titleClinical Microbiology and Infectionpor
rcaap.rightsrestrictedAccesspor
rcaap.typearticlepor

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Pergigao_CMI_2013.pdf
Size:
311.15 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: